Literature DB >> 11284036

Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis.

R Wang1, Y J Lu, C Fisher, J A Bridge, J Shipley.   

Abstract

Data on the chromosome aberrations associated with leiomyosarcomas of soft tissues are limited, complex, and incomplete. The aim of this study was to characterize genetic aberrations associated with this tumor group, to identify consistent regions of involvement and to determine correlations with clinical outcome. Chromosomes were prepared from 10 primary soft-tissue leiomyosarcoma samples, and preparations from four of them, plus the cell line SK-LMS-1, were suitable for analysis using 24-color karyotyping by multifluor fluorescence in situ hybridization. This method allowed rearranged chromosomes to be characterized, which would not have been possible by banding analysis alone. The remaining six chromosome preparations were analyzed using standard Giemsa banding. The chromosome imbalances associated with all the samples were determined by comparative genomic hybridization analysis. Taken together, the results show both intra- and intertumor heterogeneity and considerable complexity. Although no highly consistent rearrangements were found, some regions of the genome frequently were involved, including 1q21, 5p14-pter, and 20q13, which likely harbor genes that play a role in the pathogenesis of soft-tissue leiomyosarcomas. There were no obvious correlations between the chromosomal changes identified and available clinical details. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11284036     DOI: 10.1002/gcc.1118

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

1.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

2.  Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.

Authors:  Antti Ylipää; Kelly K Hunt; Jilong Yang; Alexander J F Lazar; Keila E Torres; Dina C Lev; Matti Nykter; Raphael E Pollock; Jonathan Trent; Wei Zhang
Journal:  Cancer       Date:  2010-09-03       Impact factor: 6.860

3.  Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma.

Authors:  Ching-Yao Yang; Jau-Yu Liau; Wei-Ju Huang; Yu-Ting Chang; Ming-Chu Chang; Jen-Chieh Lee; Jia-Huei Tsai; Yi-Ning Su; Chia-Cheng Hung; Yung-Ming Jeng
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

4.  Novel approaches to treatment of leiomyosarcomas.

Authors:  Ian M Collins; David M Thomas
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

Review 5.  Genomic characteristics of soft tissue sarcomas.

Authors:  Fredrik Mertens; Ioannis Panagopoulos; Nils Mandahl
Journal:  Virchows Arch       Date:  2009-02-03       Impact factor: 4.064

Review 6.  Genetic aberrations in soft tissue leiomyosarcoma.

Authors:  Jilong Yang; Xiaoling Du; Kexin Chen; Antti Ylipää; Alexander J F Lazar; Jonathan Trent; Dina Lev; Raphael Pollock; Xishan Hao; Kelly Hunt; Wei Zhang
Journal:  Cancer Lett       Date:  2008-07-22       Impact factor: 8.679

7.  Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.

Authors:  Sara Martoreli Silveira; Rolando Andre Rios Villacis; Fabio Albuquerque Marchi; Mateus de Camargo Barros Filho; Sandra Aparecida Drigo; Cristovam Scapulatempo Neto; Ademar Lopes; Isabela Werneck da Cunha; Silvia Regina Rogatto
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  Classification, molecular characterization, and the significance of pten alteration in leiomyosarcoma.

Authors:  Allie H Grossmann; Lester J Layfield; R Lor Randall
Journal:  Sarcoma       Date:  2012-02-15

Review 9.  Recent advances in understanding and managing leiomyosarcomas.

Authors:  Florence Duffaud; Isabelle Ray-Coquard; Sébastien Salas; Patricia Pautier
Journal:  F1000Prime Rep       Date:  2015-05-12

10.  Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas.

Authors:  K T Barker; S Bevan; R Wang; Y-J Lu; A M Flanagan; J A Bridge; C Fisher; C J Finlayson; J Shipley; R S Houlston
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.